Pulverizing Metastatic Melanoma Beyond the B-RAF and N-RAS Chunks

被引：0
|
作者：
Moschos, Stergios [1 ]
机构：
[1] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
ONCOLOGIST | 2012年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [21] NFAT signalling in metastatic melanoma: a novel target for oncogenic B-RAF
    Reynolds, N.
    Flockhart, R.
    Armstrong, J.
    Lovat, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S41 - S41
  • [22] 5-Arylidene(chromenyl-methylene)-thiazolidinediones: Potential New Agents against Mutant Oncoproteins K-Ras, N-Ras and B-Raf in Colorectal Cancer and Melanoma
    Nastasa, Cristina
    Tamaian, Radu
    Oniga, Ovidiu
    Tiperciuc, Brindusa
    MEDICINA-LITHUANIA, 2019, 55 (04):
  • [23] B-RAF is a therapeutic target in melanoma
    Karasarides, M
    Chiloeches, A
    Hayward, R
    Niculescu-Duvaz, D
    Scanlon, I
    Friedlos, F
    Ogilvie, L
    Hedley, D
    Martin, J
    Marshall, CJ
    Springer, CJ
    Marais, R
    ONCOGENE, 2004, 23 (37) : 6292 - 6298
  • [24] B-RAF: A contributor to the melanoma phenotype
    Heath, E. M. L.
    Kaufman, K. L.
    Christopherson, R. I.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2011, 43 (01): : 29 - 32
  • [25] B-RAF is a therapeutic target in melanoma
    Maria Karasarides
    Antonio Chiloeches
    Robert Hayward
    Dan Niculescu-Duvaz
    Ian Scanlon
    Frank Friedlos
    Lesley Ogilvie
    Douglas Hedley
    Jan Martin
    Christopher J Marshall
    Caroline J Springer
    Richard Marais
    Oncogene, 2004, 23 : 6292 - 6298
  • [26] Erratum, The role of B-RAF in melanoma
    Vanessa C. Gray-Schopfer
    Silvy da Rocha Dias
    Richard Marais
    Cancer and Metastasis Reviews, 2005, 24 : 367 - 367
  • [27] VEMURAFENIB (B-RAF INHIBITOR) ASSOCIATED UVEITIS IN PATIENTS WITH METASTATIC CUTANEOUS MELANOMA
    Sandhu, Sukhpal S.
    Ling, Cecilia
    Lim, Lyndell
    Zamir, Ehud
    Stawell, Richard J.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 118 - 118
  • [28] K-RAS AND B-RAF MUTATIONS IN PAIRED PRIMARY AND METASTATIC COLORECTAL TUMORS
    Ko, Yoo-Joung
    Kamel-Reid, Suzanne
    Rowsell, Corwyn
    Zhang, Liying
    Yarom, Nirit
    Jonker, Derek
    ANNALS OF ONCOLOGY, 2011, 22 : v26 - v26
  • [29] The role of K-RAS and B-RAF mutations as biomarkers in metastatic colorectal cancer
    Selcukbiricik, F.
    Erdamar, S.
    Ozkurt, C. U.
    Mandel, N. Molinas
    Demirelli, F.
    Ozguroglu, M.
    Tural, D.
    Buyukunal, E.
    Serdengecti, S.
    JOURNAL OF BUON, 2013, 18 (01): : 116 - 123
  • [30] Predictors of MEK inhibitor sensitivity beyond B-raf and K-ras mutation
    Haverty, Peter
    Chan, Jocelyn
    Edgar, Kyle
    Guan, Jane
    Wallin, Jeff
    Hoeflich, Klaus
    Yauch, Robert
    Seshagiri, Somasekar
    Belvin, Marcia
    CANCER RESEARCH, 2009, 69
12345